DZ Bank analyst Elmar Kraus downgraded Novartis (NVS) to Hold from Buy with a CHF 127 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- VIG vs. VYM vs. VYMI: Which Is Vanguard’s Best Dividend ETF for Reliable Passive Income?
- Novartis breaks ground on biomedical research center in San Diego
- Trump Trade: Argentina says U.S. to cut hundreds of tariffs
- Novartis Earnings Call: Record Margins Amid Generic Wave
- Novartis price target lowered to CHF 132 from CHF 133 at Citi